Table 4 from A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors
收藏NIAID Data Ecosystem2026-05-02 收录
数据链接:
官方服务:
资源简介:
Summary of OS of each patient since the start of MVX-ONCO-1 treatment
创建时间:
2024-08-14



